Is Metoprolol Good for Treating Anxiety Symptoms?

Metoprolol can blunt the physical symptoms of anxiety, particularly a racing heart, trembling hands, and a pounding chest, but it is not approved by the FDA for treating anxiety disorders and carries a complicated profile that makes it a poor standalone choice for most people with clinical anxiety. Beta-blockers like metoprolol have a long informal history in performance-anxiety situations, yet the research on broader anxiety relief is thin and mixed. One study in heart-failure patients found genuine anxiolytic benefit over twelve months, while the same study found that metoprolol worsened depressive symptoms. That tension runs through the whole question and makes a straightforward yes-or-no answer impossible.

What Metoprolol Actually Does to Anxiety Symptoms

Metoprolol belongs to a class of drugs called beta-blockers, originally designed to treat high blood pressure, heart failure, and certain rhythm problems. It works by blocking beta-adrenergic receptors, which are the docking sites that adrenaline (epinephrine) and noradrenaline use to speed up the heart, tighten blood vessels, and activate the body’s fight-or-flight response. When those receptors are blocked, your heart rate slows, your blood pressure drops a bit, and several of the physical sensations that accompany anxiety become less intense.

This is why metoprolol can feel like it “works” for anxiety even though it was never designed for that purpose. If your anxiety manifests as a pounding heart, shaky hands, a tight chest, or a quavering voice, blocking the beta receptors dials those symptoms down directly. The drug is not doing anything to the psychological core of anxiety, the worry, dread, or rumination. It is dampening the body’s outward expression of it. For some people that physical relief is enough to break the feedback loop where noticing your own racing heart makes you more anxious, which makes your heart race harder.

The Evidence for Anxiolytic Benefit

Dedicated randomized trials of metoprolol specifically for anxiety disorders are scarce. The strongest signal comes from a study of chronic heart-failure patients who also had clinically diagnosed neuropsychiatric disorders, including anxiety. In that study, anxiety scores measured on a validated scale dropped significantly from baseline by the third month of metoprolol treatment and stayed lower through twelve months of follow-up. The reduction held across all four anxiety subgroups and was statistically robust. The researchers noted that the anxiolytic benefit appeared to be independent of heart-rate reduction, suggesting something beyond simple cardiovascular calming was going on.¹

That finding is genuinely interesting, but it comes with major caveats. The participants were heart-failure patients, not otherwise-healthy people with generalized anxiety disorder or panic disorder. Heart failure itself produces anxiety-like symptoms (shortness of breath, chest tightness, fatigue), so treating the underlying cardiac condition could reduce anxiety indirectly. Extrapolating from this population to someone who is anxious but has a healthy heart requires a leap the data does not fully support. There is no large randomized trial comparing metoprolol head-to-head with a standard anxiety treatment like an SSRI or cognitive behavioral therapy in a general anxiety population.

The Depression Trade-Off

The same study that showed metoprolol reducing anxiety scores also reported a troubling flip side. Patients with depression or high burnout saw their depressive symptoms get significantly worse after starting metoprolol, with depression scores rising within the first month and staying elevated for the full twelve-month study period.¹ This is not a small footnote. Anxiety and depression overlap heavily. Roughly half of people diagnosed with generalized anxiety disorder also meet criteria for depression at some point. If metoprolol eases one side of that coin while worsening the other, the net effect on overall mental health is unclear at best.

The link between beta-blockers and depression has been debated for decades. Some older studies suggested it was a real phenomenon; more recent analyses have been less sure. But this particular study found it clearly enough to state that metoprolol “significantly worsens depressive and high burnout symptoms.” If you are considering metoprolol for anxiety and you have any history of depression or low mood, this deserves a direct conversation with your prescriber.

A Lipophilic Drug and the Brain

Not all beta-blockers are created equal when it comes to crossing into the brain. Metoprolol is lipophilic, meaning it dissolves easily in fats, and the brain is essentially wrapped in a fatty barrier (the blood-brain barrier). Lipophilic beta-blockers cross that barrier more readily than hydrophilic (water-soluble) ones like atenolol. This matters because it means metoprolol has more opportunity to interact with receptors inside the central nervous system, for better and for worse.

On the better side, the ability to reach the brain may be part of why metoprolol seems to have some anxiolytic effect that goes beyond simple heart-rate suppression. On the worse side, metoprolol’s central nervous system penetration is also linked to a range of neuropsychiatric side effects. Case reports and reviews have documented vivid or bizarre dreams, sleep disturbances, delirium, psychosis, and visual hallucinations associated with beta-blockers, with the risk directly tied to how lipophilic the drug is.² Sleep disruption alone can worsen anxiety considerably, so a drug that reduces daytime anxiety symptoms while producing disturbing dreams and fragmented sleep at night may end up being a wash for some people.

If you are prescribed metoprolol and start experiencing unusual dreams, trouble sleeping, or mood changes that feel different from your usual anxiety pattern, those are worth reporting. Switching to a less lipophilic beta-blocker or adjusting the dose can sometimes resolve these effects while preserving whatever cardiovascular benefit the drug is providing.

Performance Anxiety Versus Generalized Anxiety

The place where beta-blockers have the strongest informal track record for anxiety is in specific, predictable performance situations: public speaking, musical auditions, job interviews, and similar high-stakes moments. In these scenarios, the physical symptoms of anxiety are often the primary problem. A violinist whose hands shake cannot play well; a speaker whose voice trembles loses the audience’s confidence. Metoprolol or its cousin propranolol, taken an hour before the event, can reduce those physical manifestations enough to let the person perform normally.

This situational use is fundamentally different from taking metoprolol daily for a chronic anxiety disorder. In a performance context, the drug is addressing a discrete episode with a known trigger and a clear endpoint. The dose is typically low, the exposure is brief, and the psychological dimensions of anxiety (catastrophic thinking, avoidance behavior, chronic worry) are managed by the person’s own coping strategies or by separate therapy. Propranolol is more commonly used for this purpose than metoprolol, partly because propranolol has a longer history in performance-anxiety research and partly because it is non-selective (blocking both beta-1 and beta-2 receptors), which may give slightly broader tremor and peripheral symptom control. Metoprolol is selective for beta-1 receptors, meaning it is more targeted to the heart and somewhat less effective at suppressing tremor in the hands and extremities.

For generalized anxiety disorder, panic disorder, social anxiety disorder, or other chronic anxiety conditions, the evidence simply does not support metoprolol as a primary treatment. Standard first-line treatments, including SSRIs, SNRIs, buspirone, and cognitive behavioral therapy, address both the physical and psychological components of anxiety and have far more clinical-trial support behind them. Beta-blockers can serve as an adjunct in certain situations, particularly when a fast heart rate is the patient’s most distressing symptom, but they are not a substitute for treatments that target anxiety at its source.

The Withdrawal Problem

One aspect of metoprolol use that people taking it for anxiety rarely anticipate is what happens when they stop. Beta-blockers, metoprolol included, should not be discontinued abruptly. When the drug is suddenly removed, the body can overshoot in the opposite direction. In a study of patients taking metoprolol for high blood pressure, abrupt withdrawal produced an average rebound increase in resting heart rate of about 15% along with a sharp rise in how sensitive the heart became to stimulation by stress hormones.³ That rebound typically peaked between two and eight days after the last dose.

Another study found that even with gradual withdrawal, metoprolol still produced a rebound increase in resting heart rate and an exaggerated heart-rate response to standing up, effects that persisted for about three weeks before settling down.⁴ A comparative study looking at three different beta-blockers found that three out of eight patients experienced withdrawal symptoms after metoprolol, including headache, palpitations, and tremor.⁵

For someone taking metoprolol to manage anxiety, this creates an ironic trap. The rebound symptoms, a racing heart, palpitations, tremor, are nearly identical to the anxiety symptoms the person was trying to treat in the first place. A person who stops metoprolol and then experiences a pounding heart and shakiness may interpret those sensations as their anxiety returning with a vengeance, when in reality it is a temporary physiological rebound that will resolve on its own. The practical takeaway is that metoprolol should always be tapered, never stopped cold, and the tapering period should be discussed with a doctor in advance.

How Your Genes Affect the Response

Metoprolol is broken down in the liver primarily by an enzyme called CYP2D6, and the gene that codes for this enzyme varies substantially from person to person. Some people are ultra-rapid metabolizers who chew through metoprolol so quickly that a standard dose barely works. Others are poor metabolizers who clear the drug slowly, resulting in higher blood concentrations, stronger effects, and a greater risk of side effects including an excessively slow heart rate.

A systematic review and meta-analysis found that patients who lack functional CYP2D6 activity experience greater reductions in blood pressure and heart rate during metoprolol treatment and face a higher risk of bradycardia (abnormally slow heart rate) compared to patients with normal enzyme activity.⁶ A separate study confirmed that specific genetic variants of CYP2D6 produce meaningfully different blood levels of metoprolol and different degrees of beta-receptor blockade throughout the day.⁷

This genetic variability means that two people taking the same dose of metoprolol can have very different experiences. One may feel nicely calmed with minimal side effects; another may feel dizzy, exhausted, and mentally foggy because the drug is accumulating to higher-than-expected levels. If you try metoprolol and find that even a low dose makes you feel wiped out or produces an unusually slow pulse, poor CYP2D6 metabolism could be the explanation. Pharmacogenomic testing, a simple cheek swab or blood draw, can identify your metabolizer status and help guide dosing. This testing is increasingly available and is particularly useful for people who seem unusually sensitive or resistant to metoprolol.

Practical Considerations if You Are Offered Metoprolol for Anxiety

If a doctor suggests metoprolol for anxiety, the context matters enormously. There are a few scenarios where it makes reasonable sense:

You already take metoprolol for your heart: If you are on the drug for high blood pressure, heart failure, or a rhythm disorder and it happens to be easing your anxiety symptoms as well, that is a welcome secondary benefit and may reduce the need for a separate anti-anxiety medication.
Your anxiety is mainly physical: If your dominant symptoms are a racing heart, visible tremor, or a sense that your heart is going to beat out of your chest, and the psychological components are mild, a beta-blocker can be a useful short-term tool while you build longer-lasting coping strategies.
You need rapid relief for a specific event: A one-time or occasional low dose before a presentation, audition, or similarly defined event is one of the more defensible off-label uses of beta-blockers for anxiety.

Scenarios where metoprolol is a poor choice for anxiety are more numerous. If you have low blood pressure or an already slow resting heart rate, the drug can push those into uncomfortable or even dangerous territory. If you have asthma or reactive airway disease, even a beta-1-selective blocker like metoprolol can trigger bronchospasm at higher doses. If depression is part of your picture, the evidence that metoprolol may worsen depressive symptoms should give you and your prescriber pause. And if your anxiety is chronic and pervasive rather than episodic, you need treatment that addresses the cognitive and emotional dimensions, not just the cardiovascular ones.

Why Beta-Blockers Persist in Anxiety Treatment Despite Limited Evidence

Given the thin evidence base, it is fair to wonder why beta-blockers keep showing up in anxiety conversations. Part of the answer is historical inertia. Propranolol was first noted to reduce anxiety symptoms in the 1960s, and the idea became embedded in medical culture before the evidence standards we use today were established. Musicians, public speakers, and surgeons quietly adopted it, and a strong word-of-mouth tradition developed that outran the formal research.

Another factor is that beta-blockers work fast. SSRIs and SNRIs take weeks to reach full effect, and that waiting period can be excruciating for someone in acute distress. Benzodiazepines work quickly but carry addiction risk and are increasingly restricted. Beta-blockers offer a middle path: rapid physical symptom relief with a low abuse potential. That practical niche keeps them in the conversation even though no major guideline recommends them as first-line anxiety treatment.

There is also a diagnostic gap at play. Many people who present with anxiety-like symptoms actually have an underlying cardiac or autonomic issue, such as inappropriate sinus tachycardia or postural orthostatic tachycardia syndrome, where a fast heart rate is the primary driver of their distress. For these people, metoprolol can be transformative, but the mechanism is treating a heart-rate disorder, not an anxiety disorder per se. If your “anxiety” is really your body’s response to a heart that runs too fast at rest, fixing the heart rate fixes the downstream distress. This is worth investigating if your anxiety came on suddenly, is primarily cardiac-feeling, and does not respond well to standard anxiety treatments.

Common Drug Interactions Worth Knowing About

Metoprolol’s reliance on the CYP2D6 enzyme for metabolism means that other medications competing for that same enzyme can effectively turn you into a poor metabolizer even if your genetics are normal. Several widely used drugs inhibit CYP2D6 and can raise metoprolol levels unexpectedly. These include fluoxetine (Prozac) and paroxetine (Paxil), which are, ironically, two of the SSRIs commonly prescribed for anxiety. If you are taking or starting one of these SSRIs alongside metoprolol, the combination can produce stronger-than-expected beta-blockade, potentially causing lightheadedness, fatigue, or an unusually slow heart rate. Bupropion (Wellbutrin), often used for depression and smoking cessation, is another potent CYP2D6 inhibitor with the same interaction risk.

The interaction is not a reason to panic, but it is a reason to make sure every prescriber involved knows the full list of medications you take. Dose adjustments can usually manage the overlap safely. It is also worth mentioning to your pharmacist, who often catches these interactions before they cause problems.